Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: eFFECTOR Therapeutics Announces $7.5 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

May 26 (Reuters) - eFFECTOR Therapeutics Inc  EFTR.O :
    * EFFECTOR THERAPEUTICS ANNOUNCES $7.5 MILLION REGISTERED
DIRECT
OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
    * EFFECTOR THERAPEUTICS - ENTERED DEFINITIVE DEAL WITH
SINGLE
INSTITUTIONAL INVESTOR FOR PURCHASE AND SALE OF 11.5MLN SHARES
OF ITS COMMON STOCK
    * EFFECTOR THERAPEUTICS INC - DEFINITIVE AGREEMENT AT
PURCHASE
PRICE OF $0.655 PER SHARE
    * EFFECTOR THERAPEUTICS INC - GROSS PROCEEDS TO CO FROM
OFFERING
ARE EXPECTED TO BE ABOUT $7.5 MILLION

Source text for Eikon:  ID:nGNX25dbDg 
Further company coverage:  EFTR.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Effector Therapeutics

See all news